Protagonist Therapeutics Inc (PTGX) — Cash Flow Reinvestment Rate
Protagonist Therapeutics Inc (PTGX) has a Cash Flow Reinvestment Rate of 0.76x as of March 2025, reinvesting $94.95 Million (capex $545.00K plus investments $-94.40 Million) from operating cash flow of $125.36 Million. Explore Protagonist Therapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Protagonist Therapeutics Inc Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Protagonist Therapeutics Inc across 2 annual periods. Also explore Protagonist Therapeutics Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Protagonist Therapeutics Inc (2017–2024)
Year-by-year capital reinvestment analysis for Protagonist Therapeutics Inc. For live market cap and broader valuation context, see PTGX market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.63x | $300.84 Million | $184.15 Million | $1.35 Million | ▼ -61.6% |
| 2017 | 4.26x | $16.49 Million | $3.87 Million | $666.00K | — |